Product name: D-Pleurocidin
Modifications: C-terminal amide,
Counter ion: Trifluoacetate
Format: Lyophilized powder
Description: D-Ple was stable in the proteases degrading of L-Ple indicated that D-amino acid substitutions could make peptides resistant to a proteolysis and thus D-Ple could exert its antimicrobial activity unimpaired. Also, this suggested that D-Ple or relevant derivatives might be potential candidates for clinical use. D-Ple showed much lower hemolytic activity than L-Ple at the highest level, and, there was no hemolysis at other concentration levels.
Usage: For Scientific Research Use Only, Not for Human Use.